anticholium
Generic: physostigmine salicylate
Labeler: provepharm inc.Drug Facts
Product Profile
Brand Name
anticholium
Generic Name
physostigmine salicylate
Labeler
provepharm inc.
Dosage Form
INJECTION
Routes
Active Ingredients
physostigmine salicylate .4 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
81284-831
Product ID
81284-831_7c1db393-3664-425f-af20-8d2175fb634e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Listing Expiration
2026-12-31
Marketing Start
2023-10-05
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
81284831
Hyphenated Format
81284-831
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
anticholium (source: ndc)
Generic Name
physostigmine salicylate (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .4 mg/mL
Packaging
- 5 AMPULE in 1 CARTON (81284-831-05) / 5 mL in 1 AMPULE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "7c1db393-3664-425f-af20-8d2175fb634e", "openfda": {"unii": ["2046ZRO9VU"], "rxcui": ["2666367", "2666374"], "spl_set_id": ["b90b50e8-c8f1-4f2d-be6e-4d269b8c362c"], "manufacturer_name": ["Provepharm Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 AMPULE in 1 CARTON (81284-831-05) / 5 mL in 1 AMPULE", "package_ndc": "81284-831-05", "marketing_start_date": "20231005"}], "brand_name": "ANTICHOLIUM", "product_id": "81284-831_7c1db393-3664-425f-af20-8d2175fb634e", "dosage_form": "INJECTION", "product_ndc": "81284-831", "generic_name": "physostigmine salicylate", "labeler_name": "Provepharm Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ANTICHOLIUM", "active_ingredients": [{"name": "PHYSOSTIGMINE SALICYLATE", "strength": ".4 mg/mL"}], "marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE", "marketing_start_date": "20231005", "listing_expiration_date": "20261231"}